Another detail out of FDA. The agency has removed pages which provide guidance to medical researchers on conducting medical trials with representative numbers of men and women and ethnic and/or racial minority groups. I think most people know this: but this isn’t a matter of symbolic diversity. Many medications and/or diseases or conditions present differently in men and woman and in people with different genetic backgrounds.
